Abstract
Exercise-induced bronchoconstriction (EIB) occurs as a distinct condition or associated with asthma. Short-acting beta2-agonist (SABA) treatment is generally recommended, but there is less consensus on anti-inflammatory therapy use. This study describes demographics, treatment patterns, and morbidity of patients with EIB vs EIB+asthma.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
